Feedback / Questions
bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
http://www.ncbi.nlm.nih.gov/pubmed/38234051
Behrokh Farahmand; Hamideh Ofoghi; Sohrab Sam
Jan 18, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next